novo nordisk glp-1 products EMA will monitor suicide risk in Nordisk's Novo Nordisk introduces NovoCare® Pharmacy,

Phentermine-topiramate exerts its anti-obesogenic effects by suppressing appetite through a catecholamine-mediated mechanism of phentermine

The complex makeup of obesity might also explain why GLP-1s don't work for many people

Consider that 4 weeks without weight loss is not necessarily a failure

Given its complexity, effective obesity management necessitates a multidisciplinary, individualized approach that combines nutritional and behavioral interventions, physical activity, pharmacological therapies, and metabolic-bariatric surgery when indicated

Banded sleeve gastrectomy and one anastomosis gastric bypass/mini-gastric bypass for treatment of obesity: a retrospective cohort comparative study with 6 years follow-up

Lu J, Ma X, Zhou J, et al